Latest filing published 03 Sept 2026 for REGENXBIO Inc., €1,878.
This profile gathers the share dealings of Craig Malzahn in REGENXBIO Inc. The record holds 4 filings, for trades running from 1 September 2025 to 1 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 3 September 2026, the filings show a share grant worth €1,878 in REGENXBIO Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations